Company Profile

AARTI DRUGS LTD.

NSE : AARTIDRUGSBSE : 524348ISIN CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse : Aarti
BSE716.7511.8 (+1.67 % )
PREV CLOSE (Rs.) 704.95
OPEN PRICE (Rs.) 712.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 34077
TODAY'S LOW / HIGH (Rs.)706.15 729.80
52 WK LOW / HIGH (Rs.)105.56 1025
NSE717.00 11.95 (+1.69 % )
PREV CLOSE(Rs.) 705.05
OPEN PRICE (Rs.) 709.95
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 717.00 (2307 )
VOLUME 854129
TODAY'S LOW / HIGH(Rs.) 705.10 730.00
52 WK LOW / HIGH (Rs.)105.25 1026.95

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.07
TTM EPS (Rs.) 24.26
P/E Ratio 29.54
Book Value (Rs.) 89.54
Face Value (Rs.) 10
MCap (Rs. in Mn) 66801.10
Price/Earning (TTM) 24.39
Price/Sales (TTM) 3.68
Price/Book (MRQ) 8.00
PAT Margin (%) 8.30
ROCE (%) 21.29
Incorporation Year : 1984

Management Info :

Prakash M Patil - Chairman Rashesh C Gogri - Managing Director

Registered Office :

Address : Plot No N 198,M I D C,Tarapur Village - Patembhi, Taluka Palghar,
Thane,
Maharashtra-401506

Phone :

Email : NA

Website : www.aartidrugs.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS More
30Oct10-30-2020$Aarti Drugs informs about press release Aarti Drugs informs about pr
Aarti Drugs has informed that it has enclosed press release titled, ‘Aarti Drugs Limited: Corporate Updates’ released on 30 October 2020

The above information is a part of company’s filings submitted to BSE. 

Aarti Drugs has informed that it has enclosed press release tit..
23Oct10-23-2020$Allotment of Equity Shares Allotment of Equity Shares
Inter alia passed an enabling resolution for raising of funds by way of issue of equity shares or any other instruments or security including fully/partly convertible debentures or by way of a composite issue of non-convertible debentures and warrants entitling the warrant holder(s) to apply for equity shares or any other eligible securities through qualified institutions placement, private placement/public issue of equity/debt securities, preferential issue or through any other permissible mode and/or combination thereof as may be considered appropriate, subject to such approvals as may be required including the approval of the members at a general meeting or through postal ballot and further subject to such other statutory/regulatory approvals, as applicable for an aggregate amount of upto Rs. 350 Crores (Rupees Three hundred and Fifty Crores). 2. declared the Interim Dividend @ Rs. 2.5/- (25%) per Equity share for the financial year 2020-21.
Inter alia passed an enabling resolution for raising of funds b..
17Oct10-17-2020$Aarti Drugs submits certificate Aarti Drugs submits certific

Aarti Drugs has informed that the Company enclosed a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2020 received from Link Intime India, Registrar and Share Transfer Agent of the Company.

The above information is a part of company’s filings submitted to BSE.

Aarti Drugs has informed that the Company enclosed a Certificat..
01Sep09-01-2020$Allotment of Equity Shares Allotment of Equity Shares
Bonus issue Inter alia, has approved the following subject to approval of the Shareholders (through Postal Ballot and e-voting): a) Increase in authorized share capital of the Company from Rs. 25,00,00,000/- (Rupees Twenty Five Crore) to Rs. 120,00,00,000/- (Rupees One hundred and Twenty Crores) by creation of additional 9,50,00,000 (Nine Crores Fifty Lakhs) Equity Shares of Rs. 10/- (Rupees Ten only) each and consequent amendment to clause V of the Memorandum of Association of the Company. b) the issuance of fully paid up Bonus Share in the ratio of 3:1 i.e. 3 (Three) Bonus Equity Share of Rs. 10/- each for 1 (One) fully paid up Equity Share of Rs. 10/- each. The Company will intimate the ?Record Date? for determining eligible Shareholders entitled to receive Bonus Shares in due course
Bonus issue Inter alia, has approved the following subject to..
01Sep09-01-2020$Result of Postal Ballot Result of Postal Ballot
Bonus issue Inter alia, has approved the following subject to approval of the Shareholders (through Postal Ballot and e-voting): a) Increase in authorized share capital of the Company from Rs. 25,00,00,000/- (Rupees Twenty Five Crore) to Rs. 120,00,00,000/- (Rupees One hundred and Twenty Crores) by creation of additional 9,50,00,000 (Nine Crores Fifty Lakhs) Equity Shares of Rs. 10/- (Rupees Ten only) each and consequent amendment to clause V of the Memorandum of Association of the Company. b) the issuance of fully paid up Bonus Share in the ratio of 3:1 i.e. 3 (Three) Bonus Equity Share of Rs. 10/- each for 1 (One) fully paid up Equity Share of Rs. 10/- each. The Company will intimate the ?Record Date? for determining eligible Shareholders entitled to receive Bonus Shares in due course
Bonus issue Inter alia, has approved the following subject to..
Financials More
Rs. in Millions
QTR Sep 20 ANNUAL 20
Net Profit697.91356.7
Gross Profit 902.9 1749.7
Operating Profit 1092.42454.6
Net Sales 5151.616349.2
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Pfizer (BSE)
 5229.90 (2.44%)
M.Cap ( in Cr)
23925.61
Procter&Gamble Healt (BSE)
 6762.20 (1.81%)
M.Cap ( in Cr)
11245.09
Jubilant LifeScience (BSE)
 788.00 (8.44%)
M.Cap ( in Cr)
12551.35
Panacea Biotec (BSE)
 245.70 (19.33%)
M.Cap ( in Cr)
1504.93
Torrent Pharma (BSE)
 2684.05 (1.19%)
M.Cap ( in Cr)
45481.61
Shareholding Pattern More
PROMOTERS 60.21 %
NON-INSTITUTION 35.45 %
MUTUAL FUNDS/UTI 1.85 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes